Link to Genecards: | SOCS5 | ALK |
ChimerKB | Top |
ChimerPUB | Top |
Fusion_pair | Translocation | PMID | Disease | Validation | Gene Type | Sentence_highlight |
---|---|---|---|---|---|---|
SOCS5_ALK | - | 25567908 | adenocarcinoma | - | - | Actionable genomic alterations with a targeted agent based on NCCN guidelines were identified in 26% [8 of 31: EGFR G719A, BRAF V600E, SOCS5-ALK, HIP1-ALK, CD74-ROS1, KIF5B-RET (n = 2), CCDC6-RET]. |
ChimerSEQ | Top |
ChiTaRS 2.1 | Top |
FARE-CAFE | Top |
TicDB | Top |
TUMOR FUSION Gene Data Portal | Top |
FusionCancer | Top |
ConjoinG | Top |
1000Genome | Top |
18Cancers | Top |
Bodymap2 | Top |
HPA | Top |
Non_Tumor_Cells | Top |
Babiceanu_Dataset | Top |
Banned_Dataset | Top |
Known_Fusions | Top |
ONGene Database | Top |
Bushman Cancer Gene Database | Top |
Tumor Gene Set By Uniprot | Top |
Oesophagus_Dataset | Top |
Gliomas_Dataset | Top |
Prostate_Dataset | Top |
Pancreases_Dataset | Top |
GTEx | Top |
Klijin_Dataset | Top |
Fimereli_Dataset | Top |
Literature | Top |
Cortex_Dataset | Top |
ChromothripsisDB | Top |